Table 1.
BP control status at 140/90 mmHg and 130/80 mmHg according to patient characteristics
| Characteristics | Controlled BP < 140/90a | P-Valueb | Controlled BP < 130/80a | P-Valueb | Overallc | ||
|---|---|---|---|---|---|---|---|
| Overall | Yes (n = 1080) | No (n = 670) | Yes (n = 635) | No (n = 1115) | N = 1750 | ||
| Age group | 0.402 | 0.891 | |||||
| ≥ 18 to < 45 | 53 (57.6) | 39 (42.4) | 33 (35.9) | 59 (64.1) | 92 (5.3) | ||
| ≥ 45 to < 65 | 253 (64.2) | 141 (35.8) | 147 (37.3) | 247 (62.7) | 394 (22.5) | ||
| ≥ 65 | 774 (61.2) | 490 (38.8) | 455 (36.0) | 809 (64.0) | 1264 (72.2) | ||
| Sex | 0.633 | 0.399 | |||||
| Male | 572 (62.2) | 347 (37.8) | 325 (35.4) | 594 (64.6) | 919 (52.5) | ||
| Female | 508 (61.1) | 323 (38.9) | 310 (37.3) | 521 (62.7) | 831 (47.5) | ||
| Indigenous (n = 1368) | 0.132 | 0.137 | |||||
| Yes | 25 (50.0) | 25 (50.0) | 13 (26.0) | 37 (74.0) | 50 (3.7) | ||
| No | 799 (60.6) | 519 (39.4) | 478 (36.3) | 840 (63.7) | 1318 (96.4) | ||
| Smoking (n = 1599) | 0.149 | 0.365 | |||||
| Yes | 88 (66.7) | 44 (33.3) | 52 (39.4) | 80 (60.6) | 132 (8.3) | ||
| No | 884 (60.3) | 583 (39.7) | 520 (35.4) | 947 (64.6) | 1467 (91.7) | ||
| Diabetes | 0.273 | 0.389 | |||||
| Yes | 590 (62.9) | 348 (37.1) | 349 (37.2) | 589 (62.8) | 938 (53.6) | ||
| No | 490 (60.3) | 322 (39.7) | 286 (35.2) | 526 (64.8) | 812 (46.4) | ||
| CVD | 0.001 | 0.001 | |||||
| Yes | 647 (65.8) | 337 (34.2) | 399 (40.5) | 585 (59.5) | 984 (56.2) | ||
| No | 433 (56.5) | 333 (43.5) | 236 (30.8) | 530 (69.2) | 766 (43.8) | ||
| Obesity (n = 1729) | 0.824 | 0.927 | |||||
| Yes | 546 (62.3) | 331 (37.7) | 322 (36.7) | 555 (63.3) | 877 (50.7) | ||
| No | 526 (61.7) | 326 (38.3) | 311 (36.5) | 541 (63.5) | 852 (49.3) | ||
| eGFR | 0.013 | 0.067 | |||||
| ≥ 45 to < 60 | 240 (66.5) | 121 (33.5) | 152 (42.1) | 209 (57.9) | 361 (20.6) | ||
| ≥ 30 to < 45 | 448 (62.2) | 272 (37.8) | 255 (35.4) | 465 (64.6) | 720 (41.1) | ||
| ≥15 to < 30 | 333 (60.4) | 218 (39.6) | 190 (34.5) | 361 (65.5) | 551 (31.5) | ||
| < 15 | 59 (50.0) | 59 (50.0) | 38 (32.2) | 80 (67.8) | 118 (6.7) | ||
| ACR/PCR (n = 1719) | 0.001 | 0.001 | |||||
| Normal | 337 (70.5) | 141 (29.5) | 209 (43.7) | 269 (56.3) | 478 (27.8) | ||
| Mild | 347 (63.2) | 202 (36.8) | 206 (37.5) | 343 (62.5) | 549 (31.9) | ||
| Severe | 379 (54.8) | 313 (45.2) | 208 (30.1) | 484 (69.9) | 692 (40.3) | ||
| # drug classes | 0.008 | 0.105 | |||||
| 0 | 36 (47.4) | 40 (52.6) | 23 (30.3) | 53 (69.7) | 76 (4.3) | ||
| 1 | 270 (67.7) | 129 (32.3) | 150 (37.6) | 249 (62.4) | 399 (22.8) | ||
| 2 | 311 (61.8) | 192 (38.2) | 176 (35.0) | 327 (65.0) | 503 (28.7) | ||
| 3 | 288 (60.8) | 186 (39.2) | 191 (40.3) | 283 (59.7) | 474 (27.1) | ||
| ≥ 4 | 175 (58.7) | 123 (41.3) | 95 (31.9) | 203 (68.1) | 298 (17.0) | ||
| Drug classes | |||||||
| RAAS inhibitors | 763 (63.1) | 446 (36.9) | 0.073 | 456 (37.7) | 753 (62.3) | 0.063 | 1209 (69.1) |
| -- ACE inhibitorsd | 450 (62.8) | 267 (37.2) | 0.453 | 278 (38.8) | 439 (61.2) | 0.071 | 717 (41.0) |
| -- ARBsd | 360 (62.6) | 215 (37.4) | 0.590 | 204 (35.5) | 371 (64.5) | 0.623 | 575 (32.9) |
| Beta-blockers | 538 (64.0) | 303 (36.0) | 0.062 | 334 (39.7) | 507 (60.3) | 0.004 | 841 (48.1) |
| CCB | 477 (57.3) | 355 (42.7) | 0.001 | 258 (31.0) | 574 (69.0) | 0.001 | 832 (47.5) |
| Diuretics | 503 (63.0) | 295 (37.0) | 0.299 | 308 (38.6) | 490 (61.4) | 0.066 | 798 (45.6) |
| Other classes | 168 (50.9) | 162 (49.1) | 0.001 | 96 (29.1) | 234 (70.9) | 0.003 | 330 (18.9) |
aRow percentage presented
bChi-square tests on relationships between BP control and each of the variables of interest
cColumn percentage presented
dSub-class of RASS inhibitors
Significant values (p<0.05) were in bold entries